Open AccessIntravitreal bevacizumab associated with photodynamic therapy in a case of polypoidal choroidal vasculopathy associated with choroidal nevus
Author(s) -
Carlos Mario Rangel,
Eva Villota,
Álvaro Fernández-Vega González,
Ronald Mauricio Sánchez-Ávila
Publication year - 2017
Publication title -
medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.59
H-Index - 148
eISSN - 1536-5964
pISSN - 0025-7974
DOI - 10.1097/md.0000000000009400
Subject(s) - medicine , photodynamic therapy , bevacizumab , visual acuity , choroidal neovascularization , ophthalmology , dermatology , nevus , fluorescein angiography , lesion , surgery , chemotherapy , melanoma , chemistry , organic chemistry , cancer research
Rationale: Report the clinical findings and management of a case of polypoidal choroidal vasculopathy associated with choroidal nevus which received combination therapy. Patient concerns: Decreased visual acuity in a woman with polypoidal choroidal vasculopathy and choroidal nevus. Diagnoses: Polypoidal choroidal vasculopathy and choroidal nevus. Interventions: The initial visual acuity was 0.5. After the first treatment with photodynamic therapy, exudation and bleeding appeared around the lesion. After this, the patient received 3 doses of intravitreal bevacizumab. Outcomes: After treatment with combination therapy, visual acuity, clinical and imaging findings improved, with no recurrence of exudation and bleeding. Lessons: Intravitreal bevacizumab as an adjunctive treatment after photodynamic therapy is a good option for patients with polypoidal choroidal vasculopathy associated with choroidal nevus.